Bisphenol A (BPA) is a widely used chemical that has been shown to adversely affect health outcomes in experimental animal studies, particularly following fetal or early life exposure. Despite widespread human exposure in the United States and developed countries, there are limited epidemiological studies on the association of BPA with adverse health outcomes. This review briefly summarizes the epidemiological literature with special emphasis on childhood health outcomes.
Introduction
Bisphenol A (BPA) is a monomeric compound synthesized as a synthetic estrogen by Dodds and Lawson in the 1930s [1] . In the early 1950s, chemists discovered BPA had desirable chemical and physical properties that could be employed in making epoxy resins and polycarbonate plastics [2 ] . Since the 1950s, the global production of BPA has soared to six billion pounds a year [3] . BPA is used in a variety of consumer products including food can linings, thermal receipts, medical equipment, tableware, toys, food/beverage storage containers, and water supply pipes. Monomers of BPA can hydrolyze and leach from epoxy resins and polycarbonate plastics into food and liquids in contact with the container. The leaching is accelerated by high temperature, acidic, and basic conditions [4] [5] [6] [7] . Over 90% of US individuals have measurable concentrations of BPA in their urine and biomonitoring studies indicate a similar magnitude of exposure in other developed countries [8 ,9 ] .
A large number of animal and a limited number of human studies suggest that BPA exposure may be associated with adverse health outcomes [10, 11 ] . As BPA has endocrinologic activity, there is concern that BPA may act on hormonally mediated pathways to disrupt normal growth and development. Prenatal and childhood exposure to BPA may be associated with altered neurodevelopment, obesity, and precocious puberty [11 ] . Gestational exposure is of particular concern given the unique susceptibility of the fetus to environmental toxicant exposures [12] . It is imperative that clinicians have accurate information and an understanding of the health effects of BPA exposure so they can advise their patients to make informed decisions. Many parents are concerned about the impact of environmental toxicants on their children's health and frequently ask their healthcare provider for advice regarding exposures to chemicals. Since human exposure to BPA is so widespread, even small adverse effects of BPA could have large public health implications [13 ] . The purpose of this review is to summarize the existing human literature and provide clinicians with the resources to address patient's questions about BPA exposure and their children's health.
women in the USA, the Netherlands, and Norway [14 ,15 ,16,17] . BPA has also been detected in amniotic and follicular fluid and infant cord blood samples [9 ] . Young children have higher urinary BPA concentrations than adults, which likely reflect their higher food intake per pound of body mass [8 ,18] . However, it is not known whether metabolic differences between adults and children partially account for the differences in urinary BPA levels. In addition, infants receiving care in the neonatal ICU may have higher BPA exposure than the general population due to intensive medical interventions and procedures [19] . BPA has a short biological half-life (5-6 h) and is glucuronidated by phase II metabolism and rapidly eliminated in the urine after ingestion [20] .
The primary source of BPA exposure in adults is oral intake from canned food [21, 22] . Breast milk and polycarbonate feeding bottles are the predominant source of BPA exposure among infants, whereas oral exposure from canned foods becomes the primary source of BPA exposure as children age [21] . Occupationally exposed persons, such as cashiers and persons employed in industries using BPA, have additional nondietary exposures [23, 24] . Secondhand and active tobacco smoke may be an additional source of BPA exposure, since BPA is used as a component of cigarette filters [23, 25] .
Epidemiological studies
Although hundreds of experimental studies on animals have assessed the biological response to and toxicity of prenatal and early postnatal BPA exposure, a limited number of human studies have been conducted [10] . After conducting a literature search, we located 22 peer-reviewed epidemiological studies [14 ,15 ,24,26-40,41 ,42-44] that examined relationships between BPA exposure and human health outcomes (Table 1 ). The majority (n ¼ 16) of these studies were cross-sectional or case-control studies. Only six epidemiological studies examined health outcomes in children. Few of the 22 studies examined the same health outcomes. However, outcomes could be grouped and reviewed as categories of cancer [34] , reproductive [24,26-29,31,33, 35,39,41 ,42-44] , metabolic [30, 36] , pubertal development [32, 38] , infant and childhood growth [15 ,37,40] , and neurodevelopment outcomes [14 ] . Given that there is relatively little literature on the health effects of BPA exposure in children, we summarize the known literature to date, with special emphasis on findings related to the fetus and child.
Cancer
One case-control study examined the association between BPA exposure and breast cancer (70 cases and 82 controls) [34] . No information was provided on the type, stage, or grade of the tumors. The authors concluded there was no difference in mean serum BPA concentrations among cases and controls. However, women with breast cancer had higher median serum BPA concentrations than women without breast cancer. Because BPA has a short half-life, concurrent serum BPA concentrations may not reflect the etiologically relevant window of exposure for the development of breast cancer, which is years to decades before clinical recognition.
Reproductive outcomes
Because BPA is a suspected endocrine disrupting compound, several studies examined sex steroids, sexual function, and ovarian response as a target of BPA exposure. Epidemiological studies among adults have observed associations between urinary BPA concentrations and serum reproductive hormones [27, 29, 31, 44] . The findings of these studies provide some evidence that BPA exposure may be associated with increased serum follicle stimulating hormone (FSH), lutenizing hormone (LH), sex hormone binding globulin (SHBG), and testosterone concentrations in men. Two additional studies reported sexual dysfunction in occupationally exposed men in China and suggest that high BPA exposure may be associated with sexual dysfunction [24, 28] . Mok-Lin et al. [35] reported that urinary BPA concentrations were associated with decreased serum estradiol concentrations and number of oocytes among women undergoing in-vitro fertilization (IVF). Although these findings suggest potential associations between BPA exposure and reproductive health endpoints, they may not be relevant to pediatric populations, their clinical impact is uncertain, and the range of exposure in some of these studies exceeds that observed in typical pediatric populations. 
Key points
Biomonitoring studies suggest that human exposure to BPA is ubiquitous in industrialized countries. Few studies have examined the relationship between prenatal and postnatal BPA exposures and childhood health outcomes, but results from animal studies suggest some cause for concern.
Additional high-quality prospective cohort studies with multiple prenatal and postnatal BPA measurements are needed to address current research gaps. Clinicians can counsel concerned patients to reduce or avoid potential sources of BPA exposure. Li et al.
[28]
Cross-sectional 427 Unexposed: 1.2 mg/g a ; exposed: 53.7 mg/g a Self-reported sexual dysfunction in BPA exposed male workers and nonexposed controls Urinary BPA concentrations were associated with decreased male sexual function
Li et al.
[24]
Cross-sectional 550 Unexposed: 1.2 mg/g a ; exposed: 57.9 mg/g a Self-reported sexual dysfunction in BPA exposed male workers and nonexposed controls Occupational BPA exposure associated with increased odds of erectile dysfunction, ejaculation difficulty, and reduced sexual desire Meeker et al. Positive correlations between urinary BPA and serum liver enzyme concentrations were also observed. These cross-sectional studies are limited by their design. CVD and metabolic disorders have long latency periods and contemporaneous urinary BPA concentrations may not reflect the relevant etiologic window for the development of cardiovascular and metabolic diseases, which is known to be years or decades earlier. It is also important to note that animal studies show that prenatal BPA exposure may influence the development of metabolic disorders [45] . Thus, fetal exposure to BPA may be more important to the development of metabolic disorders than later life exposure.
Pubertal development outcomes
As BPA is an endocrine disrupting compound, early life exposure may increase the risk for altered pubertal development, which in turn is a risk factor for breast cancer [46, 47] . Some rodent studies suggest that early life BPA exposure may accelerate pubertal development and increase breast cancer risk [48, 49] . However, the National Toxicology Program Center for the Evaluation of Risks to Human Reproduction (NTP-CERHR) had minimal concern over BPA accelerating pubertal development [10] . To date, two epidemiological studies have examined the relationship between BPA exposure and pubertal development [32, 38] .
A cross-sectional study in New York City, New York, USA examined the correlation between concurrent BPA exposure and pubertal development in 192 nine-year-old girls [38] . [32] .
Compared with the lowest quintile of urinary BPA concentrations, the odds of advanced breast development (stage 2þ) were similar but slightly below the null (ORs between 0.95 and 0.97) for the top four quintiles, with no discernible dose-response pattern. Compared with the first quintile of urinary BPA concentrations, the odds of advanced pubic hair development (stage 2þ) were slightly increased in the second (OR 1.03; 95% CI 0.96-1.09) and third (OR 1.06; 95% CI 0.99-1.13) quintiles of urinary BPA concentrations and null in the fourth and fifth quintiles. The authors did not report whether BMI modified the association between urinary BPA concentrations and pubertal development.
Both of these studies observed ORs with similar direction and magnitude between urinary BPA concentrations and stage 2þ breast development, indicating that BPA exposure was associated with slightly later breast development. However, findings from the prospective cohort indicate accelerated pubic hair development only among girls in the second and third quintiles of urinary BPA concentrations compared with girls in the first quintile. The presence of nonmonotonic dose-response curves has been previously reported in the BPA toxicology literature, and the expectation of linear dose-response functions may not be appropriate when studying endocrine disrupting compounds [50] .
These two studies had relatively small effect sizes, and there are several important limitations, including the potential for residual confounding by measured and unmeasured confounders, and the potential for differential pharmacokinetics among prepubertal and pubertal girls to account for differences in urinary BPA concentrations. The role of childhood BPA exposure in pubertal development requires further study. Given the short halflife of BPA and temporal variability of urinary BPA concentrations, a single spot urine sample may not correctly classify exposures that occurred prenatally or much earlier in childhood, which may be more strongly related to pubertal development. Studies examining the association between BPA exposure and pubertal development in boys are also needed.
Fetal and childhood growth outcomes
Three studies examined associations between BPA exposure and infant/childhood growth [15 ,37,40] . A cross-sectional study examined associations between maternal serum BPA concentrations and birth outcomes in 40 mother-infant pairs in Ann Arbor, Michigan, USA [37] . The authors concluded there was no association between serum BPA concentrations and birth weight or gestational age; however, numerical results were not presented. Their figure suggests lower birth weight among infants born to mothers with serum BPA concentrations more than 5 mg/l. A prospective birth cohort of 367 women in New York City, New York, USA examined the association between multiple nonpersistent toxicant exposures, including BPA, in the third trimester (25-40 weeks) of pregnancy and infant birth weight, length, head circumference, and gestational age [15 ] . Prenatal urinary BPA concentrations were associated with increases in birth weight (38 g; 95% CI À6 to 82 g), length (0.1 cm; 95% CI À0.1 to 0.4 cm), head circumference (0.1 cm; 95% CI À0.1 to 0.3 cm), and no change in gestational age (0 weeks; 95% CI À0.2 to 0.2 weeks). Although these findings were nonsignificant, the association between urinary BPA concentrations and birth weight was the largest, but one of the least precise, estimates among all the toxicant exposures examined. The direction of observed effects was discrepant in these two studies. This could be due to different methods (urine vs. serum) and timing (third trimester vs. birth) of BPA exposure.
A cross-sectional pilot study of 6-8-year-old female children (n ¼ 90) from Cincinnati, OH; San Francisco California; and New York, New York, USA found a suggestive correlation between urinary BPA concentrations and BMI [40] . Urinary BPA concentrations were lower (2.2 vs. 3.7 mg/g) among children with BMI in the 85th percentile or more, which is typically used to define overweight status during childhood. These findings are surprising given that BPA may partition into fat compartments [51] .
Neurodevelopmental outcomes
A single prospective birth cohort of 249 mothers and infants from Cincinnati, Ohio, USA examined the association between prenatal BPA exposure and childhood behavior at 2 years of age [14 ] . The authors measured urinary BPA concentrations twice during pregnancy (16 and 26 weeks' gestation) and at birth. Mean gestational BPA concentrations and those from samples taken at 16 weeks' gestation were positively associated with externalizing behaviors (aggression and hyperactivity) in children, but this association was strongest in female children (b for mean BPA concentration: 6.0; 95% CI 0.1-12.0). The magnitudes of the observed associations were similar to those seen for other environmental toxicants and neurodevelopment ($0.5 SD), but the clinical relevance of this association and its persistence into later childhood needs to be determined.
Conclusion
There providers can practice primary prevention by learning about BPA exposure sources and potential health impacts through a variety of resources listed in Table 2 , including handouts created by university-based Pediatric Environmental Health Specialty Units (http://www.aoec. org/ PEHSU/facts.html). Providers can counsel patients to reduce BPA exposure by avoiding canned foods when possible, using plastic products with a 1, 2, 4, or 5 in their recycling symbol or glassware, and avoiding plastic products with a 3, 6, or 7 in their recycling symbol. They can also consult physicians professionally trained in environmental health to help address specific medical conditions that may be related to BPA and other endocrine disrupting chemical exposures.
